Polmacoxib-d6

SL-9792

Polmacoxib-d₆, >98%

Related CAS No. : [301692-76-2] of the unlabelled compound

Synonyms : CG-100649-d₆

IUPAC Name : 4-(4-(3-Fluorophenyl)-2,2-bis(methyl-d₃)-5-oxo-2,5-dihydrofuran-3-yl)benzenesulfonamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is a deuterium labelled version of Polmacoxib, which is an orally administered nonsteroidal anti-inflammatory drug (NSAID) that acts as a dual inhibitor of COX-2 and carbonic anhydrase. It is indicated for managing pain and inflammation related to osteoarthritis of the hip and knee. Additionally, Polmacoxib has been shown to inhibit colorectal adenoma and tumor growth in mouse models.

References : Kim S. H. et al.: Invest New Drugs 32(6), 1105-1112, 2014; Flick C. A. et al.: J. Med. Chem., 60(15), 6480-6515, 2017.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.